http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007099940-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b521066b1953afec4b1f31a47a55d9a4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-02 |
filingDate | 2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cccb4d770d3ef98793b84f03a119c7c |
publicationDate | 2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2007099940-A1 |
titleOfInvention | Pth agonists |
abstract | This invention relates to compounds of formula (I) n nwherein A is S, O, N, or CH; B is S, O, N, or CH; n R 1 and R 2 are the same or are different and are C 1-8 alkyl, C 2-8 alkylene, C 3-8 cycloalkyl, aryl, heteroaryl, heterocycloalkyl, C 3-6 cycloalkylaryl, or heterocycloaryl; wherein said alkyl, alkylene, cycloalkyl, aryl, heteroaryl, heterocyclyl, cycloalkylaryl, or heterocycloaryl are unsubstituted or substituted by one or more groups selected from the group consisting of halogen, C 1-8 alkyl, C 1-8 alkoxy, C 1-8 thioalkoxy, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, CF 3 , SCF 3 , NHC(O) n R 5 , S(O) m R 5 , S(O) 2 NR 5 R 6 , C(S)NR 5 R 6 , CONR 5 R 6 , C(O) n R 5 ; n is 0, 1 or 2; m is 0, 1 or 2; n R 5 is hydrogen, alkyl, aryl, alkylaryl, heterocycloalkyl, or heteroaryl and is unsubstituted or substituted by one or more groups selected from the group consisting of alkyl, C 1-8 alkoxy, aryl, heteroaryl, halogen, NO 2 , CN, N 3 , SCF 3 , and CF 3 ; n R 6 is hydrogen, alkyl, aryl, alkylaryl, heterocycloalkyl, or heteroaryl and is unsubstituted or substituted by one or more groups selected from the group consisting of alkyl, C 1-8 alkoxy, aryl, heteroaryl, halogen, NO 2 , CN, N 3 , SCF 3 , and CF 3 , or when R 1 and/or R 2 contains S(O) 2 NR 5 R 6 , CONR 5 R 6 , or C(S)NR 5 R 6 , then R 5 R 6 together with the nitrogen may form a heterocyclic ring; or a pharmaceutically acceptable salt or solvate thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993462-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487517-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010128521-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9458173-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9428505-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9000159-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104854106-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012120532-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8987278-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9474758-B2 |
priorityDate | 2004-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1119.